This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Food Safety Act of 2013 | |
|---|---|
| Name | Food Safety Act of 2013 |
| Enacted by | United States Congress |
| Effective date | 2013 |
| Signed by | Barack Obama |
| Statutes at large | 2013 |
| Related legislation | Federal Food, Drug, and Cosmetic Act, Public Health Service Act |
Food Safety Act of 2013 The Food Safety Act of 2013 is landmark United States legislation addressing foodborne illness prevention, inspection reform, and supply-chain regulation. Enacted during the 113th United States Congress and signed into law by Barack Obama, the Act amended existing statutes including the Federal Food, Drug, and Cosmetic Act and intersected with authorities of the Food and Drug Administration, the United States Department of Agriculture, and the Centers for Disease Control and Prevention. The law formed part of a broader regulatory response to outbreaks such as those attributed to Escherichia coli, Salmonella, and Listeria monocytogenes.
Legislative momentum followed high-profile outbreaks and reports from entities like the Centers for Disease Control and Prevention and the Government Accountability Office, prompting hearings in the United States Senate Committee on Health, Education, Labor, and Pensions and the United States House Committee on Energy and Commerce. Influential advocates included public health experts from Johns Hopkins Bloomberg School of Public Health, consumer groups such as Consumer Reports and Center for Science in the Public Interest, and industry stakeholders including the Food Marketing Institute and United Fresh Produce Association. The bill drew on past regulatory work under the Federal Food, Drug, and Cosmetic Act and policy proposals from the Institute of Medicine and the World Health Organization. In floor debates within the United States Senate and the United States House of Representatives, members referenced precedents like the Meat Inspection Act and the Pure Food and Drug Act while negotiating preemption clauses and funding levels.
Major provisions revised inspection frequency, hazard analysis, and mandatory recall authority, referencing standards used by the Codex Alimentarius Commission and surveillance models from the Centers for Disease Control and Prevention. The Act expanded the Food and Drug Administration's authority to require preventive controls, supplier verification, and product tracing similar to frameworks employed by the European Food Safety Authority and regulatory practices in Canada. It strengthened registration and recordkeeping requirements for facilities formerly covered under the Public Health Service Act, enhanced science-based rulemaking with input from the National Academies of Sciences, Engineering, and Medicine, and codified interagency coordination with the United States Department of Agriculture and the Environmental Protection Agency. The law included provisions on foreign supplier verification modeled on trade standards enforced by World Trade Organization members and incorporated HACCP-style preventive controls historically associated with Paul L. R. Hutton's work and institutional guidance from the Food Safety Modernization Act discourse.
Implementation relied on rulemaking at the Food and Drug Administration and cooperative agreements with state agencies such as the California Department of Public Health and the New York State Department of Health. Enforcement actions invoked administrative tools used by other agencies like the Federal Trade Commission and legal remedies available through the United States District Court for the District of Columbia. The Act funded capacity-building grants distributed through programs administered by the Centers for Disease Control and Prevention and partnerships with academic centers including Tufts University Friedman School of Nutrition Science and Policy and Cornell University's food safety programs. Cross-border coordination used mechanisms employed by the International Food Safety Authorities Network and liaison offices in consulates such as those run by United States Department of State posts in trading partners like Mexico and China.
Proponents cited reduced incidence estimates from studies at Johns Hopkins Bloomberg School of Public Health and analytic models used by the RAND Corporation, while critics raised concerns echoed by groups including the National Association of State Departments of Agriculture and the National Farmers Union. Industry trade associations such as the National Restaurant Association and the American Frozen Food Institute argued about compliance costs and supply-chain burdens; consumer advocates like the Center for Science in the Public Interest emphasized stronger public-health protections. Litigation testing preemption and administrative discretion reached courts including the United States Court of Appeals for the D.C. Circuit and prompted commentary from scholars at Harvard Law School and Yale Law School. International trading partners, represented by delegations from the European Union and Canada, monitored conformity with World Trade Organization obligations.
Subsequent amendments and complementary statutes included revisions paralleling the Food Safety Modernization Act's continuing regulatory architecture and adjustments through appropriations by the United States Congress and guidance updates from the Food and Drug Administration. Related legislative activity involved oversight by the Senate Committee on Agriculture, Nutrition, and Forestry and proposals debated in the House Committee on Agriculture. Judicial interpretations referenced precedent from cases involving the Federal Food, Drug, and Cosmetic Act and administrative law principles articulated in decisions by the United States Supreme Court. International harmonization efforts continued through the Codex Alimentarius Commission and bilateral frameworks with partners such as Mexico and Canada.
Category:United States federal food and drug legislation